Our Perspectives

market access

Shining a Light: Understanding the Complexities of Rare Diseases and Orphan Drug Development

Rare Disease Day will take place on February 29th this year and is a global opportunity to raise awareness for the individuals and families facing...

Read More

Health Equity in Focus: Addressing Disparities in Healthcare

In the ever-evolving landscape of healthcare, a challenge persists – the unequal distribution, access, and quality of care for individuals. In...

Read More

Emerging Trends in Therapeutic Development: What Lies Ahead

Therapeutic innovation drives patient treatment updates and improves patient outcomes. From the development of chemotherapy to monoclonal antibody...

Read More

Decoding the Landscape: A Comprehensive Guide to US Market Access and Payor Dynamics

Payors are major stakeholders in the US healthcare system and shape patient access, health spending, and reimbursement. In this blog post, we will...

Read More

From Concept to Reality: Navigating to the Complexities of Medical Device Innovation

Beyond reviewing and approving drugs, the FDA plays a pivotal role in overseeing and approving medical devices, a realm defined by its innovation,...

Read More

Unlocking the Power of Systematic Literature Reviews in Your Value Communication Strategy

In today's fast-paced world, where information overload is the norm, the need for evidence-based decision-making has never been greater. Systematic...

Read More

From Rx to Over-the-Counter: Narcan's Role in Combating the Opioid Epidemic

The recent approval of Narcan as an over-the-counter drug is a landmark decision that has the potential to save thousands of lives and highlights the...

Read More

White House Initiative on Women’s Health Research

Despite decades of advancement in medical research, disparities in women’s health continue to impact patient outcomes and quality of life. The White...

Read More

Decoding Drug Pricing in the ERA of IRA: From Lab to Patients' Wallets

The journey from the research lab to a patient’s bedside for a drug is long, costly, and risky. Manufacturers make significant investments over many...

Read More